The National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, announced the availability of supplemental funding for eligible NIBIB-supported research grants to facilitate collaborative work among researchers in the United States and India.

Related posts:

1. MedicareCard.com – U.S. Commerce Department, NIH, NSF Announce Challenge The U.S. Department of Commerce's Office of Innovation and Entrepreneurship and Economic Development Administration (EDA), today announced a new $12 million innovation competition, in partnership with the National Institutes of Health (NIH) and National Science Foundation (NSF)....
2. Medicare Card, NIH Funds 10 International Centers of Excellence for Malaria Research In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world....
3. NIH Announces New Awards in Program to Expand Interdisciplinary Research Careers in Women’s Health Almost $6 million has been awarded to investigators and programs to help researchers in the early stages of careers in women’s health research. The funding is from the National Institutes of Health’s Office of Research on Women’s Health (ORWH) and other co-sponsors. The money will go to 12 new and continuing Building Interdisciplinary Research Careers [...]...
4. Medicare Medical Care, Rapid Development of Drug-Resistant, 2009 H1N1 Influenza Reported in Two Cases Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Doctors who treat prolonged influenza infection should be aware that even a short course of antiviral treatment may lead to drug-resistant virus, say the authors, and clinicians should consider this possibility as they develop initial treatment strategies for their patients who have impaired immune function....
5. Medicare, NIH Expands National Network for Transforming Clinical and Translational Research Nine health research centers have received funds to develop ways to reduce the time it takes for clinical research to become treatments for patients. The funds were awarded as part of the Clinical and Translational Science Awards (CTSA) program which is led by the National Center for Research Resources (NCRR), part of the National Institutes [...]...
6. MedicareCard.com – Meeting Announcement, Careers in Global Mental Health The NIMH Office for Research on Disparities & Global Mental Health invites qualified and early career professionals to the Careers in Global Mental Health meeting on July 30, 2010....
7. MedicareCard.com Counts – 2010 Census: Why Is It Important? MedicareCard.com Counts - 2010 Census: Why Is It Important?...
8. MedicareCard.com, U.S. Latinos, Have High Rates of Developing Vision Loss, Certain Eye Conditions Latinos have higher rates of developing visual impairment, blindness, diabetic eye disease, and cataracts than non-Hispanic whites, researchers found. ...
9. MedicareCard.com – NIH Announces Ten Awards for Centers for Population Health and Health Disparities The National Institutes of Health announced today the awarding of 10 new Centers for Population Health and Health Disparities, designed to better understand and address inequities associated with the two leading causes of death in the United States — cancer and heart disease....
10. MedicareCard.com – Adding Coronary Calcium Score to Traditional Risk Factors Improves Risk Assessment for Heart Disease Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard coronar...
11. Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a [...]...
12. MedicareCard.com, National Institutes, Health-Sponsored Workshop Provides Guidelines for Soy Research Participants in a workshop sponsored by the National Institutes of Health have developed guidelines on designing and evaluating clinical research studies investigating soy, representing the first guidelines of their kind in the field of soy research. The guidelines are published in the June 2010 issue of The Journal of Nutrition....
13. Vitamin D Status is Not Associated with Risk for Less Common Cancers Despite hopes that higher blood levels of vitamin D might reduce cancer risk, a large study finds no protective effect against non-Hodgkin lymphoma or cancer of the endometrium, esophagus, stomach, kidney, ovary, or pancreas. In this study, carried out by researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, and [...]...
14. NIH Seeks to Break New Ground in Reducing Health Disparities The National Institutes of Health today launched a multidisciplinary network of experts who will explore new approaches to understanding the origins of health disparities, or differences in the burden of disease among population groups. Using state-of-the-science conceptual and computational models, the network’s goal is to identify important areas where interventions or policy changes could have [...]...
15. NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute [...]...

One Response to “NIBIB and the Indian Department of Biotechnology Collaborate to Develop Low-Cost Medical Devices”